Serum visfatin, vascular endothelial growth factor and matrix metalloproteinase-9 in women with polycystic ovary syndrome.
about
Serum visfatin, vascular endothelial growth factor and matrix metalloproteinase-9 in women with polycystic ovary syndrome.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Serum visfatin, vascular endot ...... ith polycystic ovary syndrome.
@en
Serum visfatin, vascular endot ...... ith polycystic ovary syndrome.
@nl
type
label
Serum visfatin, vascular endot ...... ith polycystic ovary syndrome.
@en
Serum visfatin, vascular endot ...... ith polycystic ovary syndrome.
@nl
prefLabel
Serum visfatin, vascular endot ...... ith polycystic ovary syndrome.
@en
Serum visfatin, vascular endot ...... ith polycystic ovary syndrome.
@nl
P2093
P2860
P1476
Serum visfatin, vascular endot ...... with polycystic ovary syndrome
@en
P2093
Basil C Tarlatzis
Dimitrios Vavilis
Eleni Bili
Kalliopi Dambala
P2860
P304
P356
10.1080/09513590.2017.1296425
P577
2017-03-16T00:00:00Z